Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-002945
Filing Date
2024-01-08
Accepted
2024-01-08 16:19:01
Documents
1
Period of Report
2023-12-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 11538
  Complete submission text file 0000950170-24-002945.txt   13208
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Issuer) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O 4D MOLECULAR THERAPEUTICS INC. 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address
Kirn David (Reporting) CIK: 0001834021 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39782 | Film No.: 24520386